Urinary Biomarkers for Early Diagnosis of Lung Cancer

J Clin Med. 2021 Apr 16;10(8):1723. doi: 10.3390/jcm10081723.


Lung cancer is the leading cause of cancer deaths worldwide. Its early detection has the potential to significantly impact the burden of the disease. The screening and diagnostic techniques in current use suffer from limited specificity. The need therefore arises for a reliable biomarker to identify the disease earlier, which can be integrated into a test. This test would also allow for the recurrence risk after surgery to be stratified. In this context, urine could represent a non-invasive alternative matrix, with the urinary metabolomic profile offering a potential source for the discovery of diagnostic biomarkers. This paper aims to examine the current state of research and the potential for translation into clinical practice.

Keywords: biomarker; early diagnosis; lung cancer; urine.